Cargando…

PB2122: A PHASE 1/2 MULTI-CENTER, DOSE-FINDING STUDY INVESTIGATING THE SAFETY, TOLERABILITY, PK AND EFFICACY OF ZN-D5, A NOVEL BCL-2 INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY AL AMYLOIDOSIS

Detalles Bibliográficos
Autores principales:	Kastritis, Efstathios, Matous, Jeffrey, Berdeja, Jesus, Abro, Emad, Augustson, Bradley, Perianes, Valentin Cabañas, Cibeira, M. Theresa, Cohen, Yael, Fong, Michael, Gatt, Moshe, DE LA Calle, Veronica Gonzalez, Kwok, Fiona, Lavi, Noa, Magen, Hila, Oriol, Albert, Palladini, Giovanni, Stockerl-Goldstein, Keith, Eves, Taylor, Zheng, Cheng, Fiorino, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429019/ http://dx.doi.org/10.1097/01.HS9.0000975252.55444.26

Ejemplares similares